157 related articles for article (PubMed ID: 23817299)
1. Neuroendocrine neoplasms of the stomach.
Louthan O
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):455-60. PubMed ID: 23817299
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours.
Min BH; Hong M; Lee JH; Rhee PL; Sohn TS; Kim S; Kim KM; Kim JJ
Br J Surg; 2018 Oct; 105(11):1480-1486. PubMed ID: 29893418
[TBL] [Abstract][Full Text] [Related]
3. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
[TBL] [Abstract][Full Text] [Related]
4. Correlation between a short-term intravenous octreotide suppression test and response to antrectomy in patients with type-1 gastric neuroendocrine tumours.
Murugesan SV; Steele IA; Dimaline R; Poston GJ; Shrotri M; Campbell F; Varro A; Pritchard DM
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):474-81. PubMed ID: 23249603
[TBL] [Abstract][Full Text] [Related]
5. Gastric Neuroendocrine Tumors (Carcinoids).
Gluckman CR; Metz DC
Curr Gastroenterol Rep; 2019 Mar; 21(4):13. PubMed ID: 30868284
[TBL] [Abstract][Full Text] [Related]
6. Review article: the investigation and management of gastric neuroendocrine tumours.
Basuroy R; Srirajaskanthan R; Prachalias A; Quaglia A; Ramage JK
Aliment Pharmacol Ther; 2014 May; 39(10):1071-84. PubMed ID: 24628514
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?
Scherübl H; Cadiot G; Jensen RT; Rösch T; Stölzel U; Klöppel G
Endoscopy; 2010 Aug; 42(8):664-71. PubMed ID: 20669078
[TBL] [Abstract][Full Text] [Related]
8. [Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: good prognosis with early detection].
Scherübl H; Faiss S; Jahn HU; Liehr RM; Schwertner C; Steinberg J; Stölzel U; Weinke T; Zimmer T; Klöppel G
Dtsch Med Wochenschr; 2009 Jul; 134(30):1529-35. PubMed ID: 19603370
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of lymph node metastasis in patients with gastric neuroendocrine tumor with normal serum gastrin level.
Jung JH; Choi KD; Koh YW; Park YS; Jung HY; Lee GH; Song HJ; Kim DH; Choi KS; Lee JH; Ahn JY; Kim MY; Bae SE; Kim JH
Hepatogastroenterology; 2015; 62(137):207-13. PubMed ID: 25993755
[TBL] [Abstract][Full Text] [Related]
10. Management of gastric carcinoids (neuroendocrine neoplasms).
Kidd M; Gustafsson BI
Curr Gastroenterol Rep; 2012 Dec; 14(6):467-72. PubMed ID: 22976575
[TBL] [Abstract][Full Text] [Related]
11. [Gastric neuroendocrine tumors].
Louthan O
Vnitr Lek; 2009 Oct; 55(10):961-6. PubMed ID: 19947241
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of gastric neuroendocrine tumours.
Plöckinger U
Wien Klin Wochenschr; 2007; 119(19-20):570-2. PubMed ID: 17985089
[TBL] [Abstract][Full Text] [Related]
13. Treatment of type I gastric neuroendocrine tumors with somatostatin analogs.
Khuroo MS; Khuroo MS; Khuroo NS
J Gastroenterol Hepatol; 2010 Mar; 25(3):548-54. PubMed ID: 20074162
[TBL] [Abstract][Full Text] [Related]
14. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?
Cavalcoli F; Zilli A; Conte D; Ciafardini C; Massironi S
Scand J Gastroenterol; 2015; 50(11):1397-403. PubMed ID: 26059834
[TBL] [Abstract][Full Text] [Related]
15. [Gastric neuroendocrine tumor].
Díaz-Sánchez CL; Molano Romero RA; Martínez González M; Márquez Rivera ML; Halabe-Cherem J
Rev Gastroenterol Mex; 1998; 63(2):97-100. PubMed ID: 10068736
[TBL] [Abstract][Full Text] [Related]
16. Gastric and duodenal neuroendocrine tumours.
O'Toole D; Delle Fave G; Jensen RT
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):719-35. PubMed ID: 23582915
[TBL] [Abstract][Full Text] [Related]
17. [Differentiated surgical therapy for neuroendocrine tumours (NET) of the stomach].
Gockel I; Watzka F; Musholt TJ; Lang H
Zentralbl Chir; 2010 Jun; 135(3):203-9. PubMed ID: 20549583
[TBL] [Abstract][Full Text] [Related]
18. Long-term endoscopic and clinical follow-up of untreated type 1 gastric neuroendocrine tumours.
Ravizza D; Fiori G; Trovato C; Fazio N; Bonomo G; Luca F; Bodei L; Pelosi G; Tamayo D; Crosta C
Dig Liver Dis; 2007 Jun; 39(6):537-43. PubMed ID: 17433795
[TBL] [Abstract][Full Text] [Related]
19. [Carcinoid tumors of the stomach in atrophic autoimmune gastritis: classification, differential diagnosis and prognosis].
Rappel S; Rindi G; Bordi C; Capella C; Solcia E; Altendorf-Hofmann A; Stolte M
Verh Dtsch Ges Pathol; 1996; 80():199-207. PubMed ID: 9065002
[TBL] [Abstract][Full Text] [Related]
20. Tumour markers in neuroendocrine tumours.
Oberg K; Janson ET; Eriksson B
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S160-2. PubMed ID: 10604122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
